An analysis of sensitivity for UC detection and specificity among other cancers, benign lesions, and non-neoplastic individuals was conducted for the three-marker combined model (PPM1 N, TMEM220, and VIM) as well as for each marker individually. This evidence concerns the gene TMEM220 and cancer.